Funded Tech Companies
Booster Therapeutics
Researching who provided funding to Booster Therapeutics? Apollo Health Ventures, private investors and Novo Holdings put venture money into this innovative life sciences company.
Company Overview
Company Name
Booster Therapeutics
Company Status
Private & Independent
Industry
Life Sciences
Funding Rounds
Total Funding
Contact Information
Mailing Address
Schlueterstr. 36
Berlin, 10629
Germany
Berlin, 10629
Germany
Phone
Undisclosed
Website
Email Address
Company Background Information
Overview
Proteasomes degrade damaged, misfolded, or unnecessary proteins. To date, protein degradation therapeutics have mainly focused on tagging individual proteins of concern with a protein called ubiquitin, inducing their degradation. While this approach holds promise, it does not address the broader issue of natural proteasome dysfunction which affects many protein pathways and contributes to many major diseases. Our approach is designed to restore the proteasome's full potential with therapeutics to address complex diseases.
Profile
Social Media
Company News
Facebook
YouTube
Last Transaction
10/10/2024
Financing History
Date
Type
Amount
Management Team
Title
Name
Email & Social
Chairman
Patrick Trojer
Co-Founder
Diogo Feleciano
Co-Founder
Darci Trader
VP - Bus. Development
João Ribas
Company Investors
Browse more funded tech companies:
Share this article
About Our VC Transaction Database
This tech company profile is powered by VentureDeal.com, a market leader in private equity transaction data.
Additional Resources for Entrepreneurs